Discover open access scientific publications

Letter: Programmed Cell Death Protein-1 (PD-1)-targeted Immunotherapy in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data From an International Multicentre Real-World Cohort-More Questions Than Answers